BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yao Y, Wang X, Zhou D, Li H, Qian H, Zhang J, Jiang L, Wang B, Lin Q, Zhu X. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway. Aging (Albany NY) 2020;12:13059-75. [PMID: 32615540 DOI: 10.18632/aging.103393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen D, Shen Z, Cheng X, Wang Q, Zhou J, Ren F, Sun Y, Wang H, Huang R. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression. Bioengineered 2021;12:1964-75. [PMID: 34027794 DOI: 10.1080/21655979.2021.1924545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cui S, Li X, Li R, Zhang H, Wang Y, Li Y, Zhu J, Li Z, Lin Y. FGF1 promotes the differentiation of goat intramuscular and subcutaneous preadipocytes. Anim Biotechnol 2021;:1-13. [PMID: 34939903 DOI: 10.1080/10495398.2021.2016430] [Reference Citation Analysis]
3 Zeng F, Zhang Y, Han X, Zeng M, Gao Y, Weng J. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns. Front Immunol 2020;11:609900. [PMID: 33574818 DOI: 10.3389/fimmu.2020.609900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Endo S, Matsunaga T, Nishinaka T. The Role of AKR1B10 in Physiology and Pathophysiology. Metabolites 2021;11:332. [PMID: 34063865 DOI: 10.3390/metabo11060332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Hojnik M, Frković Grazio S, Verdenik I, Rižner TL. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas. Cancers (Basel) 2021;13:3398. [PMID: 34298614 DOI: 10.3390/cancers13143398] [Reference Citation Analysis]
6 Hojnik M, Šuster NK, Smrkolj Š, Sisinger D, Grazio SF, Verdenik I, Rižner TL. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers (Basel) 2022;14:809. [PMID: 35159076 DOI: 10.3390/cancers14030809] [Reference Citation Analysis]
7 Shao X, Wu J, Yu S, Zhou Y, Zhou C. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition. Aging (Albany NY) 2021;13:22298-314. [PMID: 34552036 DOI: 10.18632/aging.203538] [Reference Citation Analysis]
8 Zhang Y, Knatko EV, Higgins M, Dayalan Naidu S, Smith G, Honda T, de la Vega L, Dinkova-kostova AT. Pirin, an Nrf2-Regulated Protein, Is Overexpressed in Human Colorectal Tumors. Antioxidants 2022;11:262. [DOI: 10.3390/antiox11020262] [Reference Citation Analysis]
9 Liu R, Zheng S, Yang CY, Yu Y, Peng S, Ge Q, Lin Q, Li Q, Shi W, Shao Y. Prognostic value of aldo-keto reductase family 1 member B10 (AKR1B10) in digestive system cancers: A meta-analysis. Medicine (Baltimore) 2021;100:e25454. [PMID: 33832153 DOI: 10.1097/MD.0000000000025454] [Reference Citation Analysis]